Rachel Fuller Brown died in Albany, New York, hospital after a prestigious career.
Rachel Fuller Brown passed away on January 14, 1980, at St. Peter’s Hospital in Albany, New York. Her death marked the end of a trailblazing career in chemistry, through which she co-developed nystatin, a life-saving antifungal antibiotic that transformed the treatment of fungal infections.
Throughout her life, Brown's contributions extended beyond her own research; she was instrumental in establishing the Brown-Hazen Fund from the proceeds of nystatin's patent. Her visionary pursuit of scientific advancement persisted in her legacy, elevating research in antifungal therapies long after her passing.
Her death was a profound loss to the scientific community, yet she leaves behind an enduring legacy of innovation and inspiration for women pursuing careers in science.